MANAGEMENT & ADVISORS
Officers & Directors
David Mikulis, MD, FRCR
Dr. Mikulis is Full Professor and Co-Director of Medical Imaging Research in the Dept. of Medical Imaging at the University of Toronto and the University Health Network. He is also Director of the Radiology Residency Research Program, and Director of the Functional Imaging Research Lab. Dr. Mikulis is one of the founding members of the American Society of Functional Neuroradiology (ASFNR), and currently serves on the ASFNR Executive Committee.
Seemant Chaturvedi, MD, FAHA, FAAN
Dr. Chaturvedi is Professor of Neurology at Wayne State University School of Medicine and Director of the Wayne State/Detroit Medical Center Comprehensive Stroke Program. He has co-edited the books Transient Ischemic Attacks in 2004 and Carotid Artery Stenosis: Current and Emerging Treatments in 2005. He was chairman of the American Academy of Neurology carotid endarterectomy guidelines committee, with the guidelines published in 2005. He is currently on the steering committee of several stroke prevention studies.
Colin Derdeyn, MD
Dr. Derdeyn is professor of Radiology, Neurology and Neurological Surgery at Washington University and Director of the Washington University/Barnes Jewish Hospital Stroke and Cerebrovascular Center. He is a Principal Investigator for the SAMMPRIS trial, an ongoing randomized trial of angioplasty and stenting for intracranial atherosclerotic disease. He directs the Washington University SPOTRIAS (Specialized Program for Translational Research in Acute Stroke) Center. Dr. Derdeyn also chairs the Data and Safety Monitoring Boards for two ongoing NIH funded acute stroke clinical trials (MR Rescue and ICTus 2/3).
Brendan Cunneen, CMC
A Certified Management Consultant, Brendan Cunneen is a senior business executive who has been directly involved in the development and delivery of financing and consulting programs to address the needs of Canadian entrepreneurs for over 30 years. He retired from Business Development Bank of Canada as Vice President of Consulting Services in 2009.
As part owner, Mr Cunneen then undertook the role of COO of a consulting practice, which after experiencing significant growth, was acquired by Ernst & Young LLP in 2011. Subsequently acting as Special Adviser to the Canadian Tax Practice of Ernst & Young, he was responsible for the implementation of a major growth initiative across Canada in the same practice area, including a further acquisition in 2013.
Mr Cunneen is currently active in mergers and acquisition work, and has created a Pan Canadian roster of associates filtering potential transactions and funnelling these opportunities to the correct source of capital to maximize the value of the company for its shareholders.
Steve Iscoe, PhD
Steve Iscoe, a collaborator of Dr Fisher since 1994, was a founding shareholder and president of one of the companies that became Thornhill Scientific. A retired Professor of Physiology at Queen’s University, his research focused primarily on control of the diaphragm, particularly how respiratory loads induce cardiorespiratory failure. An associated aspect was the development of a novel blood test for detecting skeletal muscle injury. His background as a respiratory physiologist contributed to the development of the company’s breathing circuits that maintain carbon dioxide levels independent of ventilation, and to their research and clinical applications.
Corporate / Engineering:
210 Dundas St. W, Suite 200
Toronto, ON, Canada M5G 2E8
Toll Free: 1-888-597-1325
T: +1 416-597-1325
F: +1 416-597-1330